Opko Health Inc

OPK

Equity

ISIN null / Valor 3094438

NASDAQ (2026-03-27)

USD 1.12-4.27%

Opko Health Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

OPKO Health Inc is a diversified healthcare company operating in diagnostics, pharmaceuticals, and biotechnology sectors. It owns BioReference Laboratories, one of the largest full-service clinical reference labs in the United States, which serves approximately 11 million patients annually. In the pharmaceutical arena, OPKO develops and markets treatments such as NGENLA™, an FDA-approved human growth hormone therapy available in over 40 markets through a partnership with Pfizer, and RAYALDEE®. The company focuses on advancing multispecific therapies to address serious conditions, including cancers and infectious diseases, supported by a research team with extensive industry experience and collaborations with major organizations like Merck, the National Institutes of Health, and BARDA. Through its integrated operations and strategic partnerships, OPKO Health aims to deliver innovative medical solutions on a global scale.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-35.6%1Y

-15.2%3Y

-74.9%5Y

Performance

39.2%1Y

55.5%3Y

58.9%5Y

Volatility